National Medicare Prescription Drug Congress

Slides:



Advertisements
Similar presentations
1 Help! I Couldnt Get My Prescription Filled: Whats Going On and What Can I Do About It? Health Action 2006 Health Assistance Partnership January 28, 2006.
Advertisements

1 THE COMMONWEALTH FUND Source: The Commonwealth Fund Health Care Opinion Leaders Survey, July Assessment of Medicare Part D Now that the first-ever.
PAS… dedicated to the advancement of the profession of pharmacy PAS the Pharmacists’ Association of Saskatchewan November 2010.
Chapter 6 Federal Regulation of Pharmacy Practice.
The Implications of the New Medicare Prescription Drug Legislation for Health Care Providers Anthony A. Barrueta Senior Counsel, Government Relations Kaiser.
Supplementing PACE through Medicare Part D
Pharmacy 483 Outcomes & Cost Management in Pharmacy Practice Janet Kelly, Pharm.D., BC-ADM February 22, 2005.
Deciphering Medicare Part D Susan Miller, Patient Education Douglas A. Magenheim, MD, MBA, FACP.
Meeting the Medication Needs of Iowans: the IowaCare Pilot Pharmaceutical Program and UIHC Medication Assistance Center Lisa Mascardo, PharmD Assistant.
Long Term Care: Medicare Prescription Drug Coverage in Institutions and Our Communities Larry Kocot Vanessa Duran.
E-Prescribing Bipartisan Policy Center “The Leaders’ Project” April 24 th, 2008 Washington DC Jonathan Roberts SVP & CIO.
TAYLOR MELANSON Providing Prescription Drug Coverage to the Elderly: America’s Experiment with Medicare Part D By Mark Duggan, Patrick Healy, and Fiona.
Iowa Collaborative Safety Net Provider Network Pharmacy Initiative U of I School of Pharmacy Pharmaceutical Management For Underserved Population.
340B Implementation: An Opportunity for Improved Health Outcomes in Communities Todd D. Sorensen, Pharm.D. Associate Professor University of Minnesota.
MEDICARE PART D Are We Ready? Are We Ready?. Medicare Part D Overview Medicare Part A and B covers individuals Age 65 and older Age 65 and older Those.
Medicare Web Site to Shine Light on Drug Prices By ROBERT PEAR Published: April 12, 2004
State Strategies: Expanding Prescription Drug Access Dee Mahan Families USA November 1, 2002.
Federal Food, Drug, and Cosmetic Act 1938, 1954, 1958 (FFDCA) Katie Buhai Period 3.
LEADERSHIP FLY-IN Washington, D.C. June 26-28, 2012 US GAPP LEADERSHIP FLY-IN Washington, D.C. June 26-28, 2012 US GAPP.
The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.
FINANCIAL ISSUES CHAPTER 14. CHAPTER OUTLINE Financial Issues Third-Party Programs – private health insurance – managed care programs – public health.
MTAC – Association Presentation August 1, P HARMACEUTICAL C ARE M ANAGEMENT A SSOCIATION About PCMA  The Pharmaceutical Care Management Association.
Medicare Reform: The Pharmacy Perspective John M. Coster, Ph.D., R.Ph. The National Medicare Prescription Drug Congress February 26, 2004.
Pharma Audioconference: PBM Regulation, Investigation, Prosecution and Compliance February 10, 2004 Stephanie W. Kanwit, Esq. Special Counsel Pharmaceutical.
 2003 Medco Health Solutions, Inc. Implications of the New Medicare Prescription Drug Legislation for Pharmaceutical Manufacturers, PBMs and Health Plans.
Avalere Health LLC | The intersection of business strategy and public policy Medicare Prescription Drug Payment Presented by Margaret Nowak September 24,
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
“USAPI-PHARMACY ASSOCIATION - RESPONSE TO NCD ROADMAP” Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa 51 st 1-18 nov 2011 Evelyn Ahhing-Faaiuaso RPH PHARMD Pihoa.
Karissa A. Laur Director, Prescription Assistance Programs Coordinating Patient Assistance Programs with Medicare Part D: A Manufacturer’s Perspective.
© 2004 Moses & Singer LLP HIPAA and Patient Privacy Issues Raised by the New Medicare Prescription Drug Program National Medicare Prescription Drug Congress.
E-Prescribe: Adopting Health Care Information Technology ADG associates presenting: Barbara Antuna Jessica Carpenter Patrick Esparza Brian Frazior.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
CMS Overview of Program Administration Medicare Coverage Gap Discount Program Public Meeting June 1, 2010.
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program The Intersection of Business Strategy and Public Policy The Health Strategies.
Pharmacy Benefit Management (PBM) 101
Managed Care Career Path for Student Pharmacists Presentation Developed for the Academy of Managed Care Pharmacy Updated February 2015.
Pharmacist Opportunities Within a Pharmacy Benefit Manager Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
340B PROGRAM AND BEST PRICE LAW HIGPA 2003 National Pharmacy Forum February 4, 2003 Presentation By Ted Slafsky Director Public Hospital Pharmacy Coalition.
MEDICATION USE IN RURAL AMERICA ASSOCIATION UPDATES National Community Pharmacists Association Tina Schlecht, PharmD, MBA Director, Pharmacy Affairs.
Financial Issues Chapter 14. Financial Issues Financial issues have a substantial influence on health care and pharmacy practice. In 1985 the average.
Formulary Manufacturer Contracting Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
Pharmacy & Therapeutics Committee Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2016.
CL This material has been created or produced by CLAIM with financial assistance, in whole or part, through a grant from the Administration for.
Regulation of Managed Care. Plan for Today Why (and why not) regulate? What is regulated? Who regulates what? Recent developments –Federal insurance market.
The Pharmacy Technician 4E
University of Texas System 2017 UT SELECT Part D Overview
Managed Care Models: The Benefit vs. Cost Balance
Greater Chicago Epilepsy Consumer Conference 2016
Pharmacy & Therapeutics Committee
PHARMACY 2012: ADDING VALUE TO THE HEALTHCARE SYSTEM
The Path to Provider Status
Open Enrollment and the Federal Landscape Jessica Kendall
Director, Pennsylvania PACE Program National Medicare Congress
Pharmacy & Therapeutics Committee
Financial and Insurance Considerations for Transplant
Federal Food, Drug, and Cosmetic Act By: Kaytlynn Martin Period 6
Third National Medicare Congress
Medicare Part D Benefit: A Primer
Prescription drug prices: Recent trends and opportunities for change
Role of the PBM In a Post-Medicare Reform World
Medicare Rx Legislation: Implications for PBMs
Kirby Bessant Vice President, Consumer Programs
Will PBMs Participate in the New Medicare Prescription Drug Program
Pharmacy & Therapeutics Committee
Medicare Reform: Implications for Pharmaceutical Manufacturers
Medicare Part D Implementation Issues: Key Decisions for States
Pharmacy Benefit Manager
Formulary Manufacturer Contracting
Pharmacy & Therapeutics Committee
Stretching Your Health Care Dollars
Presentation transcript:

National Medicare Prescription Drug Congress Background to Prescription Drug Discount Cards, the 2002 Regulations and Following Litigation and the New Medicare-Endorsed Prescription Drug Discount Card Program: How it Will Work and Who Will Participate February 27, 2004

Role of Pharmacists Patient Educator Access Point Discount Source Benefit Administrator Medication Expert

Role of Pharmacists Patient Educator Most accessible health care provider Assist Patients in Navigating the Program “Why isn’t the discount bigger?” “Which card should I use for each drug?” “Do you know how much transitional assistance I have left?” “Why isn’t this drug covered? It was last month?”

Role of Pharmacists Access Point Law requires access to brick & mortar pharmacy Networks Authorized DoD/TriCare Standards

Role of Pharmacists Discount Source Potential source of discount for plan sponsor “Secure” vs. “Negotiate” Required to pass through some of the discount from manufacturer to beneficiary No guarantee of pharmacy being “made whole”

Role of Pharmacists Benefit Administrator Card Limits Medicare-Endorsed ~ one Non-Medicare-Endorsed ~ unlimited Manufacturer-Based ~ unlimited Price Differential Information Transitional Assistance Formulary Information

Role of Pharmacists Medication Expert Partner with patients to improve medication use Partner with prescribers to advance patient care Partner with plans to provide Drug Utilization Review services Safety & Efficacy

Medicare Changes will Change Pharmacy Practice Potential for harm… Will discount card provide enough discount, from the major source of the cost? Will coverage be ‘enough’ for consumers? Sufficient compensation for medications and services? Will navigating the benefit take priority over improving medication use?

Director, Federal Government Affairs American Pharmacists Association Kristina E. Lunner Director, Federal Government Affairs American Pharmacists Association 2215 Constitution Ave. NW Washington, DC 20515 202.429.7507 klunner@APhAnet.org